Home > Boards > US OTC > Biotechs > AngioGenex, Inc. (AGGX)

"Upon effectiveness the Company which filed the Form

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
e-ore Member Profile
Member Level 
Followed By 243
Posts 21,746
Boards Moderated 8
Alias Born 01/27/09
160x600 placeholder
e-ore Member Level  Tuesday, 07/11/17 06:15:01 AM
Re: protagonist12 post# 86
Post # of 97 
"Upon effectiveness the Company which filed the Form 10 registration statement is subject to the reporting requirements of the Exchange Act. That is, they must file annual reports on Form 10-K, quarterly reports on Form 10-Q and periodic reports on Form 8-K. In addition, such Company is then subject to the proxy rules in Section 14 of the Exchange Act, and ownership rules and reporting requirements in Sections 13 and 16 of the Exchange Act."

http://securities-law-blog.com/2010/03/19/form-10-registration-statements/

My posts are my opinion. Do not be influenced by anything you read on any message board website unless you can confirm it.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist